Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

One in Seven UK High Street Shops Adopt Cashless Payments

New survey reveals a significant shift towards cashless transactions.Highlights: One in seven UK high street shops went cashless...

Morgan Stanley to Cut 2,500 Staff Across Divisions

The bank aims to streamline operations amidst economic uncertainties.Highlights: Morgan Stanley plans to cut 2,500 jobs across various...

Lloyds to Sell Customer Data to Cut IT Costs and Strengthen Fintech Position

The bank aims to optimize operations and enhance its fintech offerings.Highlights: Lloyds is selling customer data to reduce...

Robinhood Launches $695 Annual Platinum Credit Card, Challenging Amex

The new offering aims to disrupt the premium credit card market.Highlights: Robinhood's new Platinum credit card costs $695...